Baoling Bio

About:

Baoling Bio is a biomedical technology company engaged in innovative drug research and industrialization processes.

Website: http://www.zenitar.com.cn/

Top Investors: Huajin Capital, Chengdu High-tech Ceyuan Capital, Si Chuan Venture Capital, New Value Capital, Chengdu Biocity

Description:

Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia.

Total Funding Amount:

107M CNY

Headquarters Location:

Chengdu, Sichuan, China

Founded Date:

2019-01-01

Contact Email:

0008ligang(AT)sina.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-11-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai